Skip to content
EU’s plan for new pharma regulations poses challenges for industry, say experts at BIO convention
A proposal to provide the first overhaul of European Union pharma regulation in 20 years takes some positive steps but would still leave a […]
How the U.S. and Asia Pacific are collaborating to grow biotech innovation
Asian-Pacific countries and the United States are promoting biotech development through special programs to encourage their domestic industry combined with concerted efforts to attract
How the U.S. and Asia Pacific are collaborating to grow biotech innovation Read More »
Plan to reform EU pharma law elicits kudos and concerns from BIO experts
The new plan to reform European Union pharmaceutical legislation falls short on data and market protections but includes positive efforts to streamline drug approval
Plan to reform EU pharma law elicits kudos and concerns from BIO experts Read More »
USTR calls out countries needing better IP protections in annual report
Despite progress from some U.S. trading partners in developing global intellectual property protections that enable innovation, much improvement is needed, according to the Special
USTR calls out countries needing better IP protections in annual report Read More »
Hearing on public health threat from AMR puts spotlight on PASTEUR Act
Ordinary market mechanisms are inadequate against the emerging public health threat of antimicrobial resistance (AMR), lawmakers and experts agreed at the April 28 hearing
Hearing on public health threat from AMR puts spotlight on PASTEUR Act Read More »
Geno’s plant-based nylon hits global market in lululemon’s new shirt line
Major leisure-wear label lululemon is now selling men’s and women’s shirts made from Geno’s plant-based nylon, which looks and feels like traditional nylon but
Geno’s plant-based nylon hits global market in lululemon’s new shirt line Read More »
BIO webinar will advise biotech on weathering the slowing investor market
The pace of biotech investment has slowed recently, harming development at the small, new companies that are driving innovation. “Coming down from the heyday
BIO webinar will advise biotech on weathering the slowing investor market Read More »
Biotech wants to reduce animal testing and FDA is now tasked with helping
While animal activists oppose animal testing on moral grounds, the biotech industry knows that alternative technology can provide more accurate and less expensive screening
Biotech wants to reduce animal testing and FDA is now tasked with helping Read More »
BIO’s long COVID webinar furthers search for biotech solutions
When it comes to long COVID, health care providers and the biotech industry must be aware of what is already known, but we still
BIO’s long COVID webinar furthers search for biotech solutions Read More »
BIO’s online conference invites biotech to fight long COVID
While research into long COVID-19 is offering clues to causes and potential targets for treatment, defeating this debilitating condition, which impacts millions, requires a
BIO’s online conference invites biotech to fight long COVID Read More »